Read + Share
Amedeo Smart
Independent Medical Education
Casolino R, Amato F, Rae C, Puttagunta S, et al. Receptor Tyrosine kinase co-amplification and benefit from HER2 inhibitors in Biliary Tract Cancers. J Hepatol 2022 Jan 27. pii: S0168-8278(22)00025.PMID: 35093472
Email
LinkedIn
Facebook
Twitter
Privacy Policy